Myocardial dyssynchrony, heart failure aetiology, and QRS complex duration in patients with clinically manifested chronic heart failure
https://doi.org/10.15829/1560-4071-2013-2-6-11
Abstract
Aim. To assess the prevalence and clinical value of various types of left ventricular (LV) myocardial dyssynchrony in patients with systolic chronic heart failure (CHF).
Material and methods. In total, 71 patients with Functional Class (FC) II–IV CHF (LV ejection fraction (EF) <35%). The main CHF causes were coronary heart disease, CHD (65%) and non-coronary myocardial pathology (NCMP) which resulted in cardiac dilatation (35%). In 50% of the patients, QRS complex duration was
About the Authors
M. A. Trukhshina
V. A. Almazov Federal Centre of Heart, Blood, and Endocrinology, St. Petersburg, Russia
Russian Federation
Russian Federation
M. Yu. Sitnikova
V. A. Almazov Federal Centre of Heart, Blood, and Endocrinology, St. Petersburg, Russia
Russian Federation
Russian Federation
References
1. ESC Guidelines for the diagnostic and treatment of acute and chronic heart failure 2012. http://www.escardio.org/guidelines
2. National recommendations of Russian Scientific Society of Cardiologists and Society of Specialists in Heart Failure on diagnostics ant treatment of heart failure (third review from 15 December 2009) Heart Failure Journal.2009; 10, 2 (52):64–106 (Национальные рекомендации ВНОК и ОССН по диагностике и лечению ХСН (третий пересмотр от 15 декабря 2009г). Сердечная недостаточность. 2009; 10, 2 (52):64–106).
3. Gorcsan J., Abraham T. et al. Echocardiograrhy for Cardiac Resynchronization Therapy: Recommendations for performance and reporting – a Report from the American Society of Echocardiography Dyssynchrony Writing Group. ASE Expert Consensus Statement. J Am Soc Echocardiogr. 2008; 21 (3):191–213.
4. 2010 Focused Update of ESC Guidelines on device therapy in heart failure.Eur Heart J. 2010; 31:2677–87.
5. ACCF/HRS/AHA/ASE/HFSA/SCAI/SCCT/SCMR 2013 Appropriate use criteria for Implantable Cardioverter-Defibrillators and Cardiac Resynchronization Therapy. J Am Coll Cardiol. 2013; 61 (12):1323–73.
6. Clark A., Goode K., Cleland J. The prevalence and incidence of left bundle branch block in ambulant patients with chronic heart failure. Eur J Heart Fail. 2008; 10:696–702.
7. Vidal B et al Decreased likelihood of response to cardiac resynchronization therapy in patients with severe heart failure. Eur J Heart Fail. 2010; 12:283–7.
8. Bax J., Gorcsan J. Echocardiography and noninvasive imaging in cardiac resynchronization therapy. J Am Coll Cardiol.2009; 53 (21):1933–43.
9. Hawkins N., Petrie M. Selecting Patients for Cardiac Resynchronization Therapy. J Am Coll Cardiol. 2009; 53 (21):1944–59.
10. Sitnikova M. Y., Nesterova I. V., Ivanov S. G. et al. Role of specialized clinic in realization of recommendations for treatment of patients with CHF. Heart Failure Journal.2005; 6, 3 (31):105–7. (Ситникова М. Ю., Нестерова И. В, Иванов С. Г. и др.) Роль специализированной клиники в реализации рекомендаций по лечению больных с хронической сердечной недостаточностью. Сердечная недостаточность. 2005; 6, 3 (31):105–7).
Review
For citations:
Trukhshina M.A., Sitnikova M.Yu. Myocardial dyssynchrony, heart failure aetiology, and QRS complex duration in patients with clinically manifested chronic heart failure. Russian Journal of Cardiology. 2013;(2):6-11. (In Russ.) https://doi.org/10.15829/1560-4071-2013-2-6-11
Views:
798
Email this article 